HIV News and Research

RSS

Researchers gain key insights into how different types of infection-fighting T-cells survive

T-cells, or lymphocytes, are the body's natural defense mechanism against infection, directly attacking foreign bodies such as bacteria and viruses.

7 Mar 2006

Veterans research indicates mantrams can control post-traumatic stress disorder

Repeating mantrams can help control the symptoms of post-traumatic stress disorder, have a calming effect in traffic and even ease the boredom of exercise, according to a study in the latest issue of Journal of Advanced Nursing.

6 Mar 2006

Schering-Plough provides update on phase II study of Vicriviroc

Schering-Plough Corporation has provided an update on vicriviroc, its investigational CCR5 receptor antagonist, currently being evaluated by the NIH-sponsored Adult AIDS Clinical Trials Group (ACTG) in an ongoing Phase II clinical study of 118 U.S. treatment-experienced HIV patients.

6 Mar 2006

Malnutrition the root cause of half of all child deaths

According to a report by the World Bank, malnutrition is now costing poor countries as much as 3% of their annual economic output and is stunting economic development.

5 Mar 2006

Fighting the battle against disease - Leeds researchers take on the world

The five-year project will help ensure that the best treatments reach those in most need as quickly as possible, and that effective healthcare systems are established to prevent the spread of disease.

1 Mar 2006

The incidence, distribution, and control of tuberculosis

A reduction in tuberculosis (TB) incidence, prevalence and death rate can be achieved by 2015 in most parts of the world, with the greatest challenges occurring in Africa and Eastern Europe, according to a projection by the Stop TB Department of the World Health Organization.

1 Mar 2006

HAART is very cost-effective

New research shows that highly active antiretroviral therapy (HAART) is very cost-effective, despite the high price tag. However, the study also shows that reimbursement to physicians treating patients with HIV is critically low, threatening patients' access to care.

1 Mar 2006

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.

27 Feb 2006

HIV/AIDS risks reduced when mothers educate daughters

Low-income African American teen girls in Chicago continue to be at high risk for contracting HIV, but the risk decreases when their mothers teach them about the dangers of the disease, according to a new study at the University of Illinois at Chicago.

24 Feb 2006

British man had to cheat to access to HIV treatment

'Robert' says a therapy known as PEP, post-exposure prophylaxis, is not widely available and has not been well publicised and he is seeking a judicial review of government policy.

23 Feb 2006

Getting help with sexual health getting worse instead of better in the UK

According to a newly released survey, regardless of increased government spending, sexual health clinics in Britain are worse now than they were three years ago.

23 Feb 2006

Pfizer receives FDA approval for Eraxis to treat candidemia

Pfizer said today that Eraxis (anidulafungin) has been approved by the U.S. Food and Drug Administration to treat candidemia, a potentially life-threatening bloodstream infection. Candidemia is the most deadly of the common hospital-acquired bloodstream infections, with a mortality rate of approximately 40 percent.

21 Feb 2006

Animals diseases jumping to humans faster than ever before

According to scientists in the U.S. and Scotland, 75% of the 38 species of harmful organisms and viruses identified in the past 25 years are believed to have "jumped" from animals to humans.

21 Feb 2006

Dynamic duo, Clinton and India join forces to fight HIV/AIDS

Bill Clinton, in a joint venture with the Indian government is about to embark on another initiative in the fight against HIV/AIDS.

21 Feb 2006

Kids who are at highest risk for STD's are not getting tested

In the first study of its kind focusing on newly homeless youth, UCLA researchers have found that high-risk sexual behavior did not predict whether these youths were tested for sexually transmitted diseases. Instead, they were tested only when someone became pregnant or got someone pregnant.

21 Feb 2006

Emerging infectious agents pose new risks for people with bleeding disorders

An international team of scientists, including a hematologist from Thomas Jefferson University in Philadelphia, has concluded that people with bleeding disorders such as hemophilia remain at risk from emerging infectious agents in plasma and blood transfusions. For this reason, recombinant therapies, that is, those produced in the laboratory, must always be an option

16 Feb 2006

Male circumcision, HIV and other STDs

A statistical review of the past medical files of more than 300 couples in Uganda, in which the female partner was HIV negative and the male was HIV positive, provides solid documentation of the protective effects of male circumcision in reducing the risk of infection among women.

16 Feb 2006

Most Americans don't know about Health Savings Accounts

A new nationally representative poll from the Kaiser Family Foundation examines what the public took away from President Bush’s State of the Union address, finding that the health messages in the speech have yet to register with most Americans.

16 Feb 2006

Reduction in small-fiber nerves may underlie complex regional pain syndrome-I

Researchers at Massachusetts General Hospital (MGH) have found the first evidence of a physical abnormality underlying the chronic pain condition called reflex sympathetic dystrophy or complex regional pain syndrome-I (CRPS-I).

13 Feb 2006

Discovery of the molecular mechanism that inhibits HCV replication in vitro

Since its discovery several decades ago, the insidious human pathogen has stymied the quest for anti-viral therapies by refusing to reproduce in test tubes for more than a few hours or days, denying scientists an efficient virus production and infection system for experimental research.

7 Feb 2006